Rising demand for biosimilar EPO products and improved healthcare infrastructure in emerging economies are strengthening market dynamics. These converging factors are accelerating the adoption of erythropoietin drugs, thereby significantly boosting the industry's growth https://www.databridgemarketresearch.com/reports/global-erythropoietin-epo-drugs-market